Journal articles on the topic 'MOZ'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'MOZ.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Saric-Krsmanovic, Marija, Dragana Bozic, Ljiljana Radivojevic, Jelena Gajic-Umiljendic, Ljiljana Santric, and Sava Vrbnicanin. "Effects of plant growth promoting rhizobacteria (PGPR) and cover crops on seed germination and early establishment of field dodder (Cuscuta campestris Yunk.)." Pesticidi i fitomedicina 32, no. 2 (2017): 105–11. http://dx.doi.org/10.2298/pif1702105s.
Full textKatsumoto, Takuo, and Issay Kitabayashi. "MOZ Is Critical for MOZ/MLL-Fusion-Induced HoxA9/Meis1 Expression and Leukemia Development,." Blood 118, no. 21 (2011): 3467. http://dx.doi.org/10.1182/blood.v118.21.3467.3467.
Full textKatsumoto, Takuo, Kazutsune Yamagata, Yoko Ogawara, Takuro Nakamura, and Issay Kitabayashi. "Essential Role of Endogenous MOZ in Aberrant HoxA9 and Meis1 Expressions Induced By MOZ Fusion Gene." Blood 124, no. 21 (2014): 2191. http://dx.doi.org/10.1182/blood.v124.21.2191.2191.
Full textYin, Hong, Kerry L. Blanchard, and Jonathan Glass. "Altered Expression Profile of Global Genes in U937 Cells Stably Transfected with a Leukemia Fusion Gene: MOZ-TIF2." Blood 104, no. 11 (2004): 4284. http://dx.doi.org/10.1182/blood.v104.11.4284.4284.
Full textChan, Edward M., Rebecca J. Chan, Elisha M. Comer та ін. "MOZ and MOZ-CBP Cooperate with NFκB To Induce Expression of NFκB-Dependent Genes." Blood 110, № 11 (2007): 887. http://dx.doi.org/10.1182/blood.v110.11.887.887.
Full textYin, Hong, Jonathan Glass, and Kerry L. Blanchard. "The Interaction of MOZ-TIF2 with Histone Chaperon Proteins CAF-1A and Asf1b Alters MOZ Regulated Gene Expression." Blood 108, no. 11 (2006): 2208. http://dx.doi.org/10.1182/blood.v108.11.2208.2208.
Full textBozic, Dragana, Ljubinko Jovanovic, Vera Raicevic, Danijela Pavlovic, Marija Saric-Krsmanovic, and Sava Vrbnicanin. "The effect of plant growth promoting rhizobacteria on Datura stramonium L., Abutilon theophrasti Med., Onopordon acanthium L. and Verbascum thapsus L. seed germination." Pesticidi i fitomedicina 29, no. 3 (2014): 205–12. http://dx.doi.org/10.2298/pif1403205b.
Full textPaggetti, Jérôme, Romain Aucagne, Arnaud Jacquel, et al. "The Histone Acetyl-Transferase MOZ Cooperates with the Histone Methyl-Transferase MLL to Regulate HOX Gene Expression in Human Hematopoietic Stem Cells." Blood 112, no. 11 (2008): 2431. http://dx.doi.org/10.1182/blood.v112.11.2431.2431.
Full textOhta, Kumiko, Megumi Ohigashi, Ayako Naganawa, et al. "Histone acetyltransferase MOZ acts as a co-activator of Nrf2–MafK and induces tumour marker gene expression during hepatocarcinogenesis." Biochemical Journal 402, no. 3 (2007): 559–66. http://dx.doi.org/10.1042/bj20061194.
Full textKindle, Karin B., Philip J. F. Troke, Hilary M. Collins, et al. "MOZ-TIF2 Inhibits Transcription by Nuclear Receptors and p53 by Impairment of CBP Function." Molecular and Cellular Biology 25, no. 3 (2005): 988–1002. http://dx.doi.org/10.1128/mcb.25.3.988-1002.2005.
Full textKatsumoto, Takuo, Yukiko Aikawa, Takahiro Ochiya, and Issay Kitabayashi. "Roles of MOZ in Hematopoiesis." Blood 106, no. 11 (2005): 2269. http://dx.doi.org/10.1182/blood.v106.11.2269.2269.
Full textTam, Winnie F., Jennifer Rocnik, Sarah Wojiski, et al. "FLT3-ITD Cooperates with MOZ-TIF2 in Leukemogenesis in a Murine Bone Marrow Transplantation Model." Blood 108, no. 11 (2006): 1427. http://dx.doi.org/10.1182/blood.v108.11.1427.1427.
Full textKatsumoto, Takuo, and Issay Kitabayashi. "Roles of Histone Acetyltransferase MORF and MOZ in Hematopoiesis." Blood 114, no. 22 (2009): 2525. http://dx.doi.org/10.1182/blood.v114.22.2525.2525.
Full textPerez-Campo, Flor M., Julian Borrow, Valerie Kouskoff, and Georges Lacaud. "The histone acetyl transferase activity of monocytic leukemia zinc finger is critical for the proliferation of hematopoietic precursors." Blood 113, no. 20 (2009): 4866–74. http://dx.doi.org/10.1182/blood-2008-04-152017.
Full textTroke, Philip J. F., Karin B. Kindle, Hilary M. Collins, and David M. Heery. "MOZ fusion proteins in acute myeloid leukaemia." Biochemical Society Symposia 73 (January 1, 2006): 23–39. http://dx.doi.org/10.1042/bss0730023.
Full textSheikh, Bilal N., Natalie L. Downer, Belinda Phipson, et al. "MOZ and BMI1 play opposing roles during Hox gene activation in ES cells and in body segment identity specification in vivo." Proceedings of the National Academy of Sciences 112, no. 17 (2015): 5437–42. http://dx.doi.org/10.1073/pnas.1422872112.
Full textUllah, Mukta, Nadine Pelletier, Lin Xiao, et al. "Molecular Architecture of Quartet MOZ/MORF Histone Acetyltransferase Complexes." Molecular and Cellular Biology 28, no. 22 (2008): 6828–43. http://dx.doi.org/10.1128/mcb.01297-08.
Full textSHATWELL, D., J. A. CLIFFORD, D. ECHAVARRÍA, G. IRUSTA, and D. LOPEZ. "Discoveries of Low-Sulfidation Epithermal Au-Ag Veins at Cerro Negro, Deseado Massif, Argentina." SEG Discovery, no. 85 (April 1, 2011): 1–23. http://dx.doi.org/10.5382/segnews.2011-85.fea.
Full textSusiana, Andi Niartiningsih, Muh Anshar Amran, and Rochmady. "SUITABILITY OF LOCATION FOR RESTOCKING CLAMS TRIDACNIDAE IN THE SPERMONDE ARCHIPELAGO." Jurnal Ilmu dan Teknologi Kelautan Tropis 9, no. 2 (2018): 475–90. http://dx.doi.org/10.29244/jitkt.v9i2.19284.
Full textVoss, Anne K., Hannah K. Vanyai, Caitlin Collin, et al. "MOZ Regulates the Tbx1 Locus, and Moz Mutation Partially Phenocopies DiGeorge Syndrome." Developmental Cell 23, no. 3 (2012): 652–63. http://dx.doi.org/10.1016/j.devcel.2012.07.010.
Full textAikawa, Yukiko, Takuo Katsumoto, Daniel G. Tenen, and Issay Kitabayashi. "PU.1-Mediated Upregulation of M-CSFR Is Critical for MOZ-Leukemia Stem Cell Potential." Blood 114, no. 22 (2009): 216. http://dx.doi.org/10.1182/blood.v114.22.216.216.
Full textSheikh, Bilal N., Stanley C. W. Lee, Farrah El-Saafin, et al. "MOZ regulates B-cell progenitors and, consequently, Moz haploinsufficiency dramatically retards MYC-induced lymphoma development." Blood 125, no. 12 (2015): 1910–21. http://dx.doi.org/10.1182/blood-2014-08-594655.
Full textShima, Haruko, Emi Takamatsu-Ichihara, Mika Shino, et al. "Ring1A and Ring1B inhibit expression of Glis2 to maintain murine MOZ-TIF2 AML stem cells." Blood 131, no. 16 (2018): 1833–45. http://dx.doi.org/10.1182/blood-2017-05-787226.
Full textAguiar, Ricardo C. T., Andrew Chase, Stephanie Coulthard, et al. "Abnormalities of Chromosome Band 8p11 in Leukemia: Two Clinical Syndromes Can Be Distinguished on the Basis of MOZ Involvement." Blood 90, no. 8 (1997): 3130–35. http://dx.doi.org/10.1182/blood.v90.8.3130.
Full textShima, Haruko, Mika Shino, Kazutsune Yamagata, Yukiko Aikawa, Haruhiko Koseki, and Issay Kitabayashi. "Roles of Ring1A/B on Stem Cell Potential of MOZ and Other Acute Myeloid Leukemias,." Blood 118, no. 21 (2011): 3998. http://dx.doi.org/10.1182/blood.v118.21.3998.3998.
Full textFalk, Hendrik, Theresa Connor, Hong Yang, et al. "An Efficient High-Throughput Screening Method for MYST Family Acetyltransferases, a New Class of Epigenetic Drug Targets." Journal of Biomolecular Screening 16, no. 10 (2011): 1196–205. http://dx.doi.org/10.1177/1087057111421631.
Full textAyu Putri Aryani and R. Hiru Muhammad. "Proses Produksi Program Siaran “Get In The Moz“Di 90.8 FM OZ Radio Jakarta." Harmoni: Jurnal Ilmu Komunikasi dan Sosial 1, no. 4 (2023): 96–102. http://dx.doi.org/10.59581/harmoni-widyakarya.v1i4.1626.
Full textSu, Jingtian, Xuan Wang, Yuwei Bai, Moran Sun, Yongfang Yao, and Yongtao Duan. "The role of MOZ/KAT6A in hematological malignancies and advances in MOZ/KAT6A inhibitors." Pharmacological Research 174 (December 2021): 105930. http://dx.doi.org/10.1016/j.phrs.2021.105930.
Full textCirera, Laia, Charfudin Sacoor, Martin Meremikwu, et al. "The economic costs of malaria in pregnancy: evidence from four sub-Saharan countries." Gates Open Research 7 (May 5, 2023): 47. http://dx.doi.org/10.12688/gatesopenres.14375.2.
Full textCirera, Laia, Charfudin Sacoor, Martin Meremikwu, et al. "The economic costs of malaria in pregnancy: evidence from four sub-Saharan countries." Gates Open Research 7 (February 15, 2023): 47. http://dx.doi.org/10.12688/gatesopenres.14375.1.
Full textCarapeti, Melina, Ricardo C. T. Aguiar, John M. Goldman, and Nicholas C. P. Cross. "A Novel Fusion Between MOZ and the Nuclear Receptor Coactivator TIF2 in Acute Myeloid Leukemia." Blood 91, no. 9 (1998): 3127–33. http://dx.doi.org/10.1182/blood.v91.9.3127.
Full textCarapeti, Melina, Ricardo C. T. Aguiar, John M. Goldman, and Nicholas C. P. Cross. "A Novel Fusion Between MOZ and the Nuclear Receptor Coactivator TIF2 in Acute Myeloid Leukemia." Blood 91, no. 9 (1998): 3127–33. http://dx.doi.org/10.1182/blood.v91.9.3127.3127_3127_3133.
Full textKitabayashi, I. "Activation of AML1-mediated transcription by MOZ and inhibition by the MOZ-CBP fusion protein." EMBO Journal 20, no. 24 (2001): 7184–96. http://dx.doi.org/10.1093/emboj/20.24.7184.
Full textChan, Edward M., Rebecca J. Chan, Elisha M. Comer та ін. "MOZ and MOZ-CBP cooperate with NF-κB to activate transcription from NF-κB–dependent promoters". Experimental Hematology 35, № 12 (2007): 1782–92. http://dx.doi.org/10.1016/j.exphem.2007.07.015.
Full textSchmidt, H. H. "MYST3/CREBBP (MOZ/CBP) andCREBBP/MYST3 (CBP/MOZ) transcripts in AML with t(8;16)(p11;p13)." Genes, Chromosomes and Cancer 42, no. 2 (2005): 207–8. http://dx.doi.org/10.1002/gcc.20112.
Full textTavakoli, Samon, Stephanie A. Armstrong, Christina Feller, Sang Hun Hong, and Nathan T. Zwagerman. "Transpalpebral mini-orbitozygomatic approach for nonvascular skull base lesions: a single neurosurgeon’s experience." Neurosurgical Focus 56, no. 4 (2024): E11. http://dx.doi.org/10.3171/2024.1.focus23875.
Full textLiang, Jian, Leonard Prouty, B. Jill Williams, Mark A. Dayton, and Kerry L. Blanchard. "Acute Mixed Lineage Leukemia With an inv(8)(p11q13) Resulting in Fusion of the Genes for MOZ and TIF2." Blood 92, no. 6 (1998): 2118–22. http://dx.doi.org/10.1182/blood.v92.6.2118.
Full textLiang, Jian, Leonard Prouty, B. Jill Williams, Mark A. Dayton, and Kerry L. Blanchard. "Acute Mixed Lineage Leukemia With an inv(8)(p11q13) Resulting in Fusion of the Genes for MOZ and TIF2." Blood 92, no. 6 (1998): 2118–22. http://dx.doi.org/10.1182/blood.v92.6.2118.418k09_2118_2122.
Full textMishima, Yuta, Satoru Miyagi, Atsunori Saraya, et al. "The Hbo1-Brd1/Brpf2 complex is responsible for global acetylation of H3K14 and required for fetal liver erythropoiesis." Blood 118, no. 9 (2011): 2443–53. http://dx.doi.org/10.1182/blood-2011-01-331892.
Full textHuntly, Brian J. P., Hirokazu Shigematzu, Kenji Deguchi, et al. "MOZ-TIF2, but Not BCR-ABL, Confers Properties of Leukemic Stem Cells to Committed Murine Hematopoietic Progenitors." Blood 104, no. 11 (2004): 62. http://dx.doi.org/10.1182/blood.v104.11.62.62.
Full textMaki, Kazuhiro, Fumihiko Nakamura, Tetsuya Yamagata, Issay Kitabayashi, and Kinuko Mitani. "Functional Regulation of TEL through MOZ-Induced Acetylation." Blood 110, no. 11 (2007): 2647. http://dx.doi.org/10.1182/blood.v110.11.2647.2647.
Full textImataki, Osamu, and Makiko Uemura. "Sea-Blue Histiocytosis of Bone Marrow in a Patient with t(8;22) Acute Myeloid Leukemia." Case Reports in Oncology 13, no. 2 (2020): 849–52. http://dx.doi.org/10.1159/000508495.
Full textDeguchi, Kenji, Paul M. Ayton, Melina Carapeti, et al. "MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TIF2-mediated recruitment of CBP." Cancer Cell 3, no. 3 (2003): 259–71. http://dx.doi.org/10.1016/s1535-6108(03)00051-5.
Full textMichmerhuizen, Nicole L., Emily Heikamp, Masayuki Umeda, et al. "The Histone Acetyltransferase MOZ (KAT6A) Is a Molecular Dependency and Therapeutic Target in NUP98-Rearranged Acute Myeloid Leukemia." Blood 144, Supplement 1 (2024): 825. https://doi.org/10.1182/blood-2024-210529.
Full textHermans, S. J., M. C. Chung, J. B. Baell, and M. W. Parker. "Developing MOZi, a chimeric MOF protein to aid structure-based drug design in MOZ." Acta Crystallographica Section A Foundations and Advances 79, a2 (2023): C341. http://dx.doi.org/10.1107/s2053273323092744.
Full textRozman, Mar�a, and Dolors Colomer. "Reply to Schmidt ?MYST3/CREBBP (MOZ/CBP) andCREBBP/MYST3(CBP/MOZ) Transcripts in AML with t(8;16)(p11;p13)?" Genes, Chromosomes and Cancer 42, no. 2 (2005): 209. http://dx.doi.org/10.1002/gcc.20111.
Full textPeregrino, Miriane. "Moz Slam e as novas dinâmicas da poesia falada em Moçambique no século XXI." Via Atlântica 25, no. 2 (2025): 177–99. https://doi.org/10.11606/va.v25.n2.2025.215816.
Full textPlensa, Esther, Josep-Maria Ribera, José-Tomás Navarro, and Fuensanta Millà. "Leucemia aguda mieloblástica con reordenamiento de MOZ/CBP." Medicina Clínica 122, no. 16 (2004): 639. http://dx.doi.org/10.1157/13061075.
Full textPlensa, Esther, Josep-Maria Ribera, José-Tomás Navarro, and Fuensanta Millà. "Leucemia aguda mieloblástica con reordenamiento de MOZ/CBP." Medicina Clínica 122, no. 16 (2004): 639. http://dx.doi.org/10.1016/s0025-7753(04)74338-9.
Full textYin, Hong, Jonathan Glass, and Kerry L. Blanchard. "MOZ-TIF2 repression of nuclear receptor-mediated transcription requires multiple domains in MOZ and in the CID domain of TIF2." Molecular Cancer 6, no. 1 (2007): 51. http://dx.doi.org/10.1186/1476-4598-6-51.
Full text